Literature DB >> 22740879

Aberrant methylation in promoter-associated CpG islands of multiple genes in chronic myelogenous leukemia blast crisis.

Eisuke Uehara1, Seisho Takeuchi, Yang Yang, Tetsuya Fukumoto, Yoshiko Matsuhashi, Takahiro Tamura, Masahide Matsushita, Masami Nagai, H Phillip Koeffler, Taizo Tasaka.   

Abstract

Chronic myelogenous leukemia (CML) has a typical progressive course with transition from a chronic phase to a terminal blast crisis phase. The mechanisms that lead to disease progression remain to be elucidated. To understand the role of aberrant methylation in the progression of CML, DNA methylation patterns in 16 patients with CML blast crisis were analyzed. Methylation status was analyzed by methylation-specific PCR (MSP) for 13 genes, including cell cycle regulating genes, DNA repair genes, apoptosis-related genes, a differentiation-associated gene and a cytokine signaling gene. The frequency of samples with methylation in each of the following genes were: p15, 18%; MGMT, 12%; RARβ, 12%; p16, 6%; DAPK, 6% and FHIT, 6%. In total, four (25%) cases showed methylation of at least one gene. None of the 16 cases showed hypermethylation of the hMLH1 or hMSH2 genes. These results suggest that hypermethylation of cell cycle control genes, but not DNA mismatch repair genes, play a significant role in the progression of CML.

Entities:  

Year:  2011        PMID: 22740879      PMCID: PMC3362479          DOI: 10.3892/ol.2011.419

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  11 in total

1.  Chronic myelogenous leukemia in nonlymphoid blastic phase: analysis of the results of first salvage therapy with three different treatment approaches for 162 patients.

Authors:  S Sacchi; H M Kantarjian; S O'Brien; J Cortes; M B Rios; F J Giles; M Beran; C A Koller; M J Keating; M Talpaz
Journal:  Cancer       Date:  1999-12-15       Impact factor: 6.860

2.  Loss of imprinting in disease progression in chronic myelogenous leukemia.

Authors:  G S Randhawa; H Cui; J A Barletta; L Z Strichman-Almashanu; M Talpaz; H Kantarjian; A B Deisseroth; R C Champlin; A P Feinberg
Journal:  Blood       Date:  1998-05-01       Impact factor: 22.113

3.  p14ARF, p15INK4b, and p16INK4a methylation status in chronic myelogenous leukemia.

Authors:  Sophie Kusy; Marie Cividin; Nathalie Sorel; Françoise Brizard; François Guilhot; André Brizard; Christian Larsen; Joëlle Roche
Journal:  Blood       Date:  2003-01-01       Impact factor: 22.113

4.  Quantitative measure of c-abl and p15 methylation in chronic myelogenous leukemia: biological implications.

Authors:  T T Nguyen; A F Mohrbacher; Y C Tsai; J Groffen; N Heisterkamp; P W Nichols; M C Yu; M Lübbert; P A Jones
Journal:  Blood       Date:  2000-05-01       Impact factor: 22.113

5.  ABL1 methylation is a distinct molecular event associated with clonal evolution of chronic myeloid leukemia.

Authors:  F A Asimakopoulos; P J Shteper; S Krichevsky; E Fibach; A Polliack; E Rachmilewitz; Y Ben-Neriah; D Ben-Yehuda
Journal:  Blood       Date:  1999-10-01       Impact factor: 22.113

6.  Methylation analysis of cell cycle control genes in adult T-cell leukemia/lymphoma.

Authors:  W K Hofmann; K Tsukasaki; N Takeuchi; S Takeuchi; H P Koeffler
Journal:  Leuk Lymphoma       Date:  2001 Sep-Oct

7.  Absence of microsatellite instability during the progression of chronic myelocytic leukemia.

Authors:  N Mori; S Takeuchi; T Tasaka; S Lee; S Spira; D Ben-Yehuda; H Mizoguchi; G Schiller; H P Koeffler
Journal:  Leukemia       Date:  1997-01       Impact factor: 11.528

8.  High level of microsatellite instability but not hypermethylation of mismatch repair genes in therapy-related and secondary acute myeloid leukaemia and myelodysplastic syndrome.

Authors:  Mohammad H Sheikhha; Khalid Tobal; John A Liu Yin
Journal:  Br J Haematol       Date:  2002-05       Impact factor: 6.998

Review 9.  Changes in DNA methylation in neoplasia: pathophysiology and therapeutic implications.

Authors:  V Santini; H M Kantarjian; J P Issa
Journal:  Ann Intern Med       Date:  2001-04-03       Impact factor: 25.391

10.  Aberrant methylation in promoter-associated CpG islands of multiple genes in therapy-related leukemia.

Authors:  Eisuke Uehara; Seisho Takeuchi; Taizo Tasaka; Yoshiko Matsuhashi; Yang Yang; Mitsuhiro Fujita; Takahiro Tamura; Masami Nagai; H Phillip Koeffler
Journal:  Int J Oncol       Date:  2003-09       Impact factor: 5.650

View more
  7 in total

Review 1.  Role of epigenetics in chronic myeloid leukemia.

Authors:  Katerina Machova Polakova; Jitka Koblihova; Tomas Stopka
Journal:  Curr Hematol Malig Rep       Date:  2013-03       Impact factor: 3.952

2.  Aberrant hydroxymethylation in promoter CpG regions of genes related to the cell cycle and apoptosis characterizes advanced chronic myeloid leukemia disease, poor imatinib respondents and poor survival.

Authors:  Sameer Ahmad Guru; Mamta Pervin Sumi; Rashid Mir; Mirza Masroor Ali Beg; Bidhan Chandra Koner; Alpana Saxena
Journal:  BMC Cancer       Date:  2022-04-14       Impact factor: 4.430

3.  Quantitative detection of methylated NDRG4 gene as a candidate biomarker for diagnosis of colorectal cancer.

Authors:  Wenhua Xiao; Huixia Zhao; Weiwei Dong; Quiwen Li; Jianhua Zhu; Guanghui Li; Shufang Zhang; Ming Ye
Journal:  Oncol Lett       Date:  2014-12-19       Impact factor: 2.967

4.  Methylation analysis of the DAPK1 gene in imatinib-resistant chronic myeloid leukemia patients.

Authors:  Selcen Celik; Dilara Akcora; Tulin Ozkan; Nuray Varol; Sena Aydos; Asuman Sunguroglu
Journal:  Oncol Lett       Date:  2014-11-06       Impact factor: 2.967

5.  DNA methylation profiling reveals a pathological signature that contributes to transcriptional defects of CD34+ CD15- cells in early chronic-phase chronic myeloid leukemia.

Authors:  Stéphanie Maupetit-Mehouas; Franck Court; Céline Bourgne; Agnès Guerci-Bresler; Pascale Cony-Makhoul; Hyacinthe Johnson; Gabriel Etienne; Philippe Rousselot; Denis Guyotat; Alexandre Janel; Eric Hermet; Sandrine Saugues; Juliette Berger; Philippe Arnaud; Marc G Berger
Journal:  Mol Oncol       Date:  2018-04-27       Impact factor: 6.603

6.  Next-generation sequencing identifies major DNA methylation changes during progression of Ph+ chronic myeloid leukemia.

Authors:  G Heller; T Topakian; C Altenberger; S Cerny-Reiterer; S Herndlhofer; B Ziegler; P Datlinger; K Byrgazov; C Bock; C Mannhalter; G Hörmann; W R Sperr; T Lion; C C Zielinski; P Valent; S Zöchbauer-Müller
Journal:  Leukemia       Date:  2016-05-23       Impact factor: 11.528

7.  Germinal epimutation of Fragile Histidine Triad (FHIT) gene is associated with progression to acute and chronic adult T-cell leukemia diseases.

Authors:  Marcia Bellon; Izabela Bialuk; Veronica Galli; Xue-Tao Bai; Lourdes Farre; Achilea Bittencourt; Ambroise Marçais; Michael N Petrus; Lee Ratner; Thomas A Waldmann; Vahid Asnafi; Antoine Gessain; Masao Matsuoka; Genoveffa Franchini; Olivier Hermine; Toshiki Watanabe; Christophe Nicot
Journal:  Mol Cancer       Date:  2021-06-06       Impact factor: 27.401

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.